Science Translational Medicine · 2021 · 29 citations · 53 references
Life SciencesGeneticsMolecular BiologyGene ExpressionMolecular NeuroscienceNeurogeneticsGenetic DisordersHuntington DiseaseNeurogenetic DisordersPolyadenylation SignalsRna PolyadenylationThiamine DeficiencyAlternative PolyadenylationHuntington's Disease ModelsRegulation Of Polyadenylation In DiseaseThiamine-responsive DisordersTranscriptome-wide Polyadenylation Profiling
cause biotin-thiamine–responsive basal ganglia disease (BTBGD), a striatal disorder that can be treated with a combination of biotin and thiamine. Similar to patients with BTBGD, patients with HD demonstrated decreased thiamine in the cerebrospinal fluid. Furthermore, patients and mice with HD showed decreased striatal concentrations of thiamine pyrophosphate (TPP), the metabolically active form of thiamine. High-dose biotin and thiamine treatment prevented TPP deficiency in HD mice and attenuated the radiological, neuropathological, and motor HD-like phenotypes, revealing an easily implementable therapy that might benefit patients with HD.
53